drugset / Trial / NCT02939742

Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?

NCT02939742

Phase 2/3 Terminated 33 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if a repeat course of betamethasone given to pregnant women with preterm premature rupture of membranes (PPROM) will decrease the infant's length of stay in the neonatal intensive care unit (NICU) and the overall neonatal morbidity associated with this condition.

Timeline

Start
2016-11
Primary completion
2023-12-20
Completion
2023-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 12 mg Intramuscular